Vontobel Holding’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$477K Sell
16,500
-500
-3% -$12.3K ﹤0.01% 1082
2026
Q2
$365K Hold
17,000
– – ﹤0.01% 1174
2026
Q1
$236K Sell
17,000
-91
-0.5% -$1.45K ﹤0.01% 1072
2025
Q4
$278K Buy
17,091
+91
+0.5% +$1.48K ﹤0.01% 1198
2025
Q3
$254K Hold
17,000
– – ﹤0.01% 1156
2025
Q2
$198K Hold
17,000
– – ﹤0.01% 1173
2025
Q1
$126K Hold
17,000
– – ﹤0.01% 1040
2024
Q4
$102K Hold
17,000
– – ﹤0.01% 1049
2024
Q3
$87K Buy
17,000
+4,000
+31% +$17.4K ﹤0.01% 1038
2024
Q2
$47.1K Buy
+13,000
New +$41.3K ﹤0.01% 1045
2022
Q1
– Sell
-44,937
Closed -$1.27M – 1051
2021
Q4
$1.27M Sell
44,937
-2,740
-6% -$84K 0.01% 565
2021
Q3
$1.62M Buy
47,677
+39,677
+496% +$1.43M 0.01% 490
2021
Q2
$327K Hold
8,000
– – ﹤0.01% 891
2021
Q1
$322K Hold
8,000
– – ﹤0.01% 780
2020
Q4
$473K Buy
+8,000
New +$413K ﹤0.01% 666

Other funds holding ADPT

Vontobel Holding's ADPT Position: Q3 2026 in Review

Vontobel Holding reduced its Adaptive Biotechnologies (ADPT) stake by 2.9% in Q3 2026, selling an estimated $12.3K and leaving 16,500 shares worth $477K. The position accounts for ﹤0.01% of the portfolio, ranked #1082.

Vontobel Holding first reported a position in ADPT in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.62M in Q3 2021. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • Vontobel Holding held 16,500 shares of Adaptive Biotechnologies worth $477K as of Q3 2026.
  • Vontobel Holding sold 500 Adaptive Biotechnologies shares in Q3 2026, an estimated $12.3K.
  • Adaptive Biotechnologies made up ﹤0.01% of Vontobel Holding's portfolio in Q3 2026, its #1082 holding.
  • Vontobel Holding first reported a position in Adaptive Biotechnologies in Q4 2020 and has held it in 15 quarters since.
  • Vontobel Holding's Adaptive Biotechnologies position peaked at $1.62M in Q3 2021.
  • 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.